Bardoxolone (CDDO)
Bardoxolone (CDDO) (S6647-GRP)
Products
Description
Bardoxolone (CDDO), acts by releasing Nrf2 from KEAP1,is a highly potent activator of Nrf2 that induce programmed cell death (apoptosis) in cancer cells.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | S6647 |
| Target | Nrf2 |